Identification of PP2A as a novel interactor and regulator of TRIP-Br1

Z.J. Zang, L. Gunaratnam, J.K. Cheong, L.Y. Lai, L.L. Hsiao, E. O'Leary, X.M. Sun, Manuel Salto-Tellez, J.V. Bonventre, S.I.H. Hsu

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


TRIP-Br proteins area novel family of transcriptional coregulators involved in E2F-mediated cell cycle progression. Three of the four mammalian members of TRIP-Br family, including TRIP-Br1, are known oncogenes. We now report the identification of the Bot regulatory subunit of serine/threonine protein phosphatase 2A (MA) as a novel TRIP-Br1 interactor, based on an affinity binding assay coupled with mass spectrometry. A GST-TRIP-Br1 fusion protein associates with catalytically active PP2A-AB alpha C holoenzyme in vitro. Coimmunoprecipitation confirms this association in vivo. Immunofluorescence staining with a monoclonal antibody against TRIP-Br1 reveals that endogenous TRIP-Br1 and PP2A-B alpha colocalize mainly in the cytoplasm. Consistently, immunoprecipitation followed by immunodetection with anti-phosphoserine antibody suggest that TRIP-Br1 exists in a serine-phosphorylated form. Inhibition of PP2A activity by okadaic acid or transcriptional silencing of the PP2A catalytic subunit by small interfering RNA results in downregulation of total TRIP-Br1 protein levels but upregulation of serine-phosphorylated TRIP-Br1. Overexpression of PP2A catalytic subunit increases TRIP-Br1 protein levels and TRIP-Br1 co-activated E2F1/DP1 transcription. Our data support a model in which association between PP2A-AB alpha C holoenzyme and TRIP-Br1 in vivo in mammalian cells represents a novel mechanism for regulating the level of TRIP-Br1 protooncoprotein. (C) 2008 Elsevier Inc. All rights reserved.
Original languageEnglish
Pages (from-to)34-42
Number of pages9
JournalCellular Signalling
Issue number1
Publication statusPublished - Jan 2009

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'Identification of PP2A as a novel interactor and regulator of TRIP-Br1'. Together they form a unique fingerprint.

Cite this